Robust infrastructure and a talent pool with extensive global product development experience

Capabilities and expertise in an array of expression platforms that include microbial and mammalian systems

Proprietary technology based on the Pichia pastoris platform for the expression of recombinant proteins

Robust analytical capability anchored in cutting-edge tools, latest orthogonal approaches and world class technology

Scientifically rigorous, ethically compliant and stage gate-based structured preclinical and clinical development strategy

400-member strong scientific team, including MDs, PhDs and Masters degree holders, drawn from within India and global biopharma organisations

Products approved by key regulatory agencies from US, EU, Japan, France, Brazil, Mexico, Turkey and Gulf countries

Strategic global and regional partnerships across novel molecules and biosimilars

Global-scale, complex biologics manufacturing capabilities

Strong foundation in process sciences that enables the development of biologics with economical scalability and high productivity

Comprehensive presentation in biologics across Drug Substance, Drug Products (Liquid Vials, Lyophilized Vials, Cartridges & Prefilled Syringes) and Delivery Devices Reusable & Disposable Prefilled Pens)

Wide presence with marketing footprint across 120 countries